Alex Ossola

Stocks climbed higher today after a rollercoaster ride last week that ended with the Dow topping 50,000.

Today was quieter.

The Dow added 20 points, while the Nasdaq rose 0.9 percent and the S&P 500 added half a percent.

Some reports to look out for this week that could influence trading are the delayed January jobs report on Wednesday and inflation data on Friday.

Speaking of jobs, whether you're hiring, firing, looking for a promotion or a new job, we'd love to hear your impressions of the labor market and track down questions for you.

EMLS a voice memo to WNPOD at WSJ.com or leave us a message at 212-416-4328.

Make sure to include your full name and location so we can use your comments on the show.

Novo Nordisk is escalating its fight against telehealth company Hims and Hers.

This morning, we told you about how Hims and Hers dropped its plan to offer a knockoff Wagovi weight loss pill.

Today, Novo filed a lawsuit accusing Hims and Hers of violating the patents covering its Ozempic and Wagovi drugs.

Novo is trying to recapture momentum in the $70 billion weight loss drug market and trying to protect its business from companies that sell compounded versions of its drugs.

Hims and hers said the lawsuit assaults a well-established part of U.S.

pharmacy practices.

The company's shares fell 16 percent today, while Novo's rose more than 5 percent in Europe.

And grocery giant Kroger said former Walmart executive Greg Foran is its new CEO.

Kroger had been searching for a permanent leader for almost a year.

It's the biggest grocer in the U.S.

by sales after Walmart and has been focusing on keeping food costs down for customers by doing more promotions and expanding its cheaper private label products.

Kroger shares closed up 3.9 percent.

President Trump has been trying to get foreign companies to invest in U.S.